FDA Qualifies Facial PRO As New Medical Device Development Tool
Executive Summary
The US agency has qualified the FACE-Q | Aesthetics patient-reported outcome instrument through its MDDT program.
You may also be interested in...
Going PRO: FDA Suggests Best Practices For Choosing, Changing Patient-Reported Outcome Tools
Patient-Reported Outcome (PRO) instruments are the focus of a 26 January final guidance from the US agency. Sponsors can lean on the guidance when selecting, developing or modifying tools for patient data collection.
Medicare Proposes NTAP For Breakthrough Treatment Of Spinal Condition
US Medicare has granted a new technology add-on payment (NTAP) for an innovative technology designed to treat adult spinal deformity.
First EUA In US For OTC Test To Detect COVID-19, Flu, RSV Granted To Labcorp
Agency issued an emergency use authorization to Labcorp for its OTC that detects COVID-19, flu and respiratory syncytial virus.